{"489991":{"#nid":"489991","#data":{"type":"news","title":"Professor Prausnitz Wins Georgia Bio Innovation Award","body":[{"value":"\u003Cp\u003ERegents\u2019 Professor Mark Prausnitz has been selected as one of three recipients of \u003Ca title=\u0022Georgia Bio\u0022 href=\u0022http:\/\/www.gabio.org\/\u0022\u003EGeorgia Bio\u003C\/a\u003E\u2019s 2016 Innovation Awards.\u003C\/p\u003E\u003Cp\u003EThe awards, which will be presented January 28 at Atlanta\u2019s Fox Theatre, honor the department, institution, company or individuals who are forging new ground by thinking outside traditional paradigms to create unique technology.\u003C\/p\u003E\u003Cp\u003EPrausnitz, who holds the J. Erskine Love Jr. Chair at Georgia Tech\u0027s School of Chemical and Biomolecular Engineering, is being recognized for his success in translating science into useful products that will have a positive impact on the health of individuals and the population at large. He is the key scientific member of teams that have taken fundamental discoveries in microneedles and turned them into products to treat diseases of the eye and for cost-effective administration of vaccines to the global community.\u003C\/p\u003E\u003Cp\u003EPrausnitz leads a \u003Ca href=\u0022http:\/\/drugdelivery.chbe.gatech.edu\/index.html\u0022\u003Eresearch group\u003C\/a\u003E of more than 30 people working to develop novel mechanisms and technology to enhance and target drug and vaccine delivery for medical applications. His work has produced more than 220 research papers and more than 35 issued or pending U.S. patents (in addition to international filings).\u003C\/p\u003E\u003Cp\u003EIn 2011, he co-founded Clearside Biomedical, which has raised $48 million in funding and is running three phase 2 or 3 clinical trials to treat inflammatory conditions in the back of the eye using the novel microneedle injection technology developed in Prausnitz\u2019s lab.\u003C\/p\u003E\u003Cp\u003EIn 2014, he co-founded Micron Biomedical, which is a clinical-stage company that seeks to commercialize microneedle patch technology developed in Prausnitz\u0027s lab for needle-free vaccination against influenza, polio and other diseases and self-administration of biopharmaceuticals without injections.\u003C\/p\u003E\u003Cp\u003EGeorgia Bio\u0026nbsp;is the state\u2019s life science industry association whose members include pharmaceutical, biotechnology and medical device companies, medical centers, universities and research institutes, government groups and other business organizations involved in the development of life sciences related products and services.\u003C\/p\u003E\u003Cp\u003EOther winners of Georgia Bio\u0027s 2016 Innovation Award include NFANT Labs and Abeome Corporation.\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"Professor Prausnitz Wins Georgia Bio Innovation Award"}],"field_summary":[{"value":"\u003Cp\u003ERegents\u2019 Professor Mark Prausnitz has been selected as one of three recipients of Georgia Bio\u2019s 2016 Innovation Awards.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Professor Prausnitz Wins Georgia Bio Innovation Award"}],"uid":"27271","created_gmt":"2016-01-25 14:44:41","changed_gmt":"2016-10-08 03:20:27","author":"Brad Dixon","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2016-01-25T00:00:00-05:00","iso_date":"2016-01-25T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"357811":{"id":"357811","type":"image","title":"M. Prausnitz Microneedle patch","body":null,"created":"1449245767","gmt_created":"2015-12-04 16:16:07","changed":"1475895091","gmt_changed":"2016-10-08 02:51:31","alt":"M. Prausnitz Microneedle patch","file":{"fid":"202068","name":"prausnitz_r117_hires_crop.png","image_path":"\/sites\/default\/files\/images\/prausnitz_r117_hires_crop.png","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/prausnitz_r117_hires_crop.png","mime":"image\/png","size":5386575,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/prausnitz_r117_hires_crop.png?itok=cRxO4qSw"}}},"media_ids":["357811"],"groups":[{"id":"1240","name":"School of Chemical and Biomolecular Engineering"}],"categories":[{"id":"141","name":"Chemistry and Chemical Engineering"},{"id":"134","name":"Student and Faculty"}],"keywords":[{"id":"109","name":"Georgia Tech"},{"id":"171598","name":"Innovation Award"},{"id":"495","name":"Mark Prausnitz"},{"id":"167445","name":"School of Chemical and Biomolecular Engineering"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"}],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003EBrad Dixon (\u003Ca href=\u0022mailto:braddixon@gatech.edu\u0022\u003Ebraddixon@gatech.edu\u003C\/a\u003E), 404-385-2299\u003C\/p\u003E","format":"limited_html"}],"email":["braddixon@gatech.edu"],"slides":[],"orientation":[],"userdata":""}}}